Affiliation: Boston University School of Medicine
- Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infectionDavid Nunes
Section of Gastroenterology, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts 02118, USA
Am J Gastroenterol 105:1346-53. 2010..Noninvasive markers of liver fibrosis correlate with the stage of liver fibrosis, but have not been widely applied to predict liver-related mortality...
- Barriers to treatment of hepatitis C in HIV/HCV-coinfected adults with alcohol problemsDavid Nunes
Section of Gastroenterology, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts 02118, USA
Alcohol Clin Exp Res 30:1520-6. 2006..In this study, we assessed the prevalence of barriers to interferon treatment in a population of HIV/HCV-coinfected patients with current or past alcohol problems and the extent to which they received treatment to address the barriers...
- HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver diseaseDavid Nunes
Section of Gastroenterology, Boston Medical Center, Boston University, Boston, MA 02118, USA
J Acquir Immune Defic Syndr 40:538-44. 2005..The aim of the current study was to compare the diagnostic performance and characteristics of a number of noninvasive markers of hepatic fibrosis in populations of hepatitis C virus (HCV)-infected patients with and without HIV infection...
- Impact of hepatitis C on HIV progression in adults with alcohol problemsDebbie M Cheng
Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts 02118, USA
Alcohol Clin Exp Res 31:829-36. 2007..We therefore studied the association between HCV infection and markers of HIV disease progression in adults with alcohol problems...
- Effect of exposure to injection drugs or alcohol on antigen-specific immune responses in HIV and hepatitis C virus coinfectionCamilla S Graham
Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, 02115, USA
J Infect Dis 195:847-56. 2007..We wanted to determine whether IDU or alcohol affected immune responses in HCV-infected and human immunodeficiency virus (HIV)/HCV coinfected subjects...
- Predictors of treatment for hepatitis C virus (HCV) infection in drug usersCarrie Reed
Department of Epidemiology, Boston University School of Public Health, Boston, MA 02118, USA
Subst Abus 29:5-15. 2008..01, for trend). Focused strategies to overcome these potentially modifiable factors may be indicated to increase HCV treatment in affected populations...
- Hepatitis C infection is associated with depressive symptoms in HIV-infected adults with alcohol problemsHoward Libman
Division of General Medicine and Primary Care and Infectious Diseases, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
Am J Gastroenterol 101:1804-10. 2006..These data suggest that HCV may have a direct effect on neuropsychiatric function...
- Challenges in the treatment of patients coinfected with HIV and hepatitis C virus: need for team careCatherine A Fleming
Department of Medicine, Boston Medical Center, Boston University School of Medicine, MA 02118, USA
Clin Infect Dis 40:S349-54. 2005..If patients coinfected with HCV and HIV are to be treated for hepatitis C in greater numbers, these issues will need to be addressed...
- Health-related quality of life of patients with HIV disease: impact of hepatitis C coinfectionCatherine A Fleming
Department of Medicine, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts 02118, USA
Clin Infect Dis 38:572-8. 2004..These findings underscore the importance of a multidisciplinary approach to the treatment of these patient populations...
- Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCVCamilla S Graham
Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115, USA
Hepatology 40:125-32. 2004..In conclusion, subjects with coinfection have an alteration of intrahepatic HCV-specific IL-10 cytokine response that may have implications for HCV-related disease progression...
- Evaluation of liver fibrosis: a concise reviewNezam H Afdhal
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02125, USA
Am J Gastroenterol 99:1160-74. 2004..The limitations of utilization of these markers for both cross-sectional diagnosis of fibrosis and monitoring disease progression or regression are discussed...
- Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: low eligibility for interferon treatmentCatherine A Fleming
Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts 02118, USA
Clin Infect Dis 36:97-100. 2003....
- Awareness of hepatitis C diagnosis is associated with less alcohol use among persons co-infected with HIVJudith I Tsui
General Internal Medicine Section 111A1, San Francisco VA Medical Center, 4150 Clement St, San Francisco, CA 94121, USA
J Gen Intern Med 22:822-5. 2007..We adjusted for age, sex, race, homelessness, injection drug use, depressive symptoms, and having abnormal liver tests...
- Recent drug use, homelessness and increased short-term mortality in HIV-infected persons with alcohol problemsAlexander Y Walley
Clinical Addiction Research and Education CARE Unit, USA
AIDS 22:415-20. 2008..To assess the impact of recent heavy alcohol use, heroin/cocaine use, and homelessness on short-term mortality in HIV-infected persons...
- Another step forward: treating HCV infection in HIV coinfected patientsDavid Nunes
Gastroenterology 128:513-5. 2005
- Substance abuse treatment and receipt of liver specialty care among persons coinfected with HIV/HCV who have alcohol problemsAnita Palepu
Centre for Health Evaluation and Outcome Sciences, St Paul s Hospital, Department of Medicine, University of British Columbia, Vancouver, BC, Canada V6Z 1Y6
J Subst Abuse Treat 31:411-7. 2006....
- An official ATS statement: hepatotoxicity of antituberculosis therapyJussi J Saukkonen
Am J Respir Crit Care Med 174:935-52. 2006..Priorities for future studies to develop safer treatments for LTBI and for TB disease are presented...